Parnell CEO to present at Jefferies conference; CutisPharma names new CEO; West Pharmaceutical insider sells stock;

> Parnell Pharmaceuticals Holdings ($PARN) President and CEO, Robert Joseph, will be presenting at the Jefferies 2015 Healthcare Conference in New York next week. Release

> CutisPharma, a specialty pharmaceutical company that develops and distributes bulk drugs in kits used by pharmacists to create compounded medications, has named Neal Muni as its CEO. Release

> Karen Flynn, a West Pharmaceutical Services president, sold 3,091 shares of company stock last week at an average price of $55.24 for a total transaction of $170,746.84. Article

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.